Aggeris-C
Payments companies reported to CMS as associated with Aggeris-C. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Aggeris-C, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Aggeris-C
These are the largest totals companies reported as associated with Aggeris-C. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Meyrat | Dallas, TX | Neurological Surgery | $968.17 |
| Rebecca Kuo | Joliet, IL | Orthopaedic Surgery of The Spine | $169.85 |
| Mark Mikhael | Glenview, IL | Orthopaedic Surgery | $161.98 |
| Eric Roger | Amherst, NY | Neurological Surgery | $87.32 |
| Jean Louis Benae | Mckinney, TX | Neurological Surgery | $60.19 |
| Donald Ellsworth | Jacksonville, FL | Acute Care (Nurse Practitioner) | $23.60 |
| Andrew Cannestra | Jacksonville, FL | Neurological Surgery | $23.60 |
Prescribed Aggeris-C?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.